Using Wearable Devices to Monitor QT Interval and Symptoms in Adults with Long QT Syndrome

What this Trial Is About

Researchers are studying whether wearable devices can effectively monitor patients with Long QT Syndrome by measuring their hearts QT interval remotely. This observational study aims to compare wearable device ECG measurements with the current standard tests like 12-lead ECGs and ambulatory monitors to assess accuracy and variability over a 3-month period. Participants will use wearable devices, such as Fitbit, to record ECGs weekly for up to 3 months. The study will analyze the data to understand QT interval changes, symptom causes, and develop automated analysis tools for future use with machine learning techniques. This approach does not affect participants usual clinical care. During the study, participants will have their ECG data collected remotely via wearable devices and smartphones. Researchers will evaluate the accuracy of these measurements and symptom relationships while monitoring heart rhythm variability. The study lasts 3 months from enrollment, with no changes to routine care or additional invasive procedures required.

Wearable Devices for Patient Monitoring in Long QT Syndrome